Skip to main content
Figure 3 | BMC Gastroenterology

Figure 3

From: Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma

Figure 3

Representative images of tumour from case 9 showing partial response after administration of DDP-H TAC and miriplatin-TOCE. Before treatment: a, right hepatic angiography; b, computed tomography during arterial portography (CTAP). White arrow indicates tumour defect on CTAP; c, early phase of CT hepatic arteriography (CTHA); d, delayed phase of CTHA. White arrowheads indicate staining of tumour. Two months after treatment: e, right hepatic angiography; f, plain CT image; g, early phase of dynamic CT; h, delayed phase of dynamic CT. Black arrow indicates remaining lipiodol.

Back to article page